Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Chronic Disease of Skin
Interventions
DEVICE

LabiaStick#01

"This medical device has emollient agents whose main function is to increase the skin hydration, provide physical protection and decrease the symptoms and possibility of recurrence of vulvar dermatoses.~The medical device should be applied once daily, in the evening, after a gentle washing (plain water with no cleansing products), on the affected non-hairy vulvar area."

Trial Locations (6)

2805-267

Hospital Garcia da Orta, EPE, Lisbon

6200-251

Centro Hospitalar Cova da Beira EPE, Covilha

4490-405

Apomédica - Serviços Médicos Ltd, Póvoa de Varzim

4464-513

Unidade Local de Saúde de Matosinhos, Matosinhos Municipality

4200-319

Centro Hospitalar de S. João EPE, Porto

4400-129

Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E, Vila Nova de Gaia

All Listed Sponsors
collaborator

Blueclinical, Ltd.

OTHER

lead

Health Products Research and Development Lda.

OTHER